An enzyme-linked immunosorbent assay (ELISA) based on synthetic peptides identical to lentivirus envelope protein amino acid sequences was used to study serologic reactivity of lentivirus-infected domestic cats and nondomestic felids. One feline immunodeficiency virus (FIV) peptide, P237, was consistently recognized by antibodies from FIV-infected cats, but 2 other FIV peptide antigens were not. The molecular basis for this serologic reactivity was examined. Lentivirus-infected nondomestic Felis species reacted intensely with a puma lentivirus (PLV) peptide corresponding to the conserved FIV peptide. However, lentivirus-infected Panthera species, from which a different lentivirus has been isolated, did not react with the PLV. FIV-infected domestic felids also did not have significant reactivity with the PLV peptide. The peptide ELISA is comparable in sensitivity and specificity to western blot analysis and a commercial enzyme immunoassay. Unlike the other assays, however, the peptide ELISA is inexpensive, requires a small amount of serum, enables the study of specific isotype reactivity, and discriminates between antibodies to FIV and those to PLV. Antibody tests based upon the FIV and the PLV peptides should be useful for detecting the possible introduction of FIV into exotic felids or of lentiviruses from nondomestic felids into the domestic cat population.
Lentiviruses of the family Retroviridae are important pathogens of domestic cats and infect nondomestic felids, resulting in a poorly characterized disease that may complicate the management of threatened and endangered species. Feline immunodeficiency virus (FIV) infection impairs the immune system of infected cats 1 and leaves them susceptible to opportunistic organisms. Diagnosis of the disease in cats is based upon serologic reactivity with FIV antigens. These tests commonly include immunoblots of viral proteins or a commercial enzyme immunoassay (EIA). a Although the immunoblot assay is an accepted standard for the detection of antibody reactive with FIV, 4 it is expensive and requires special equipment and expertise. The EIA is easy to use, but independent verification of the assay's efficacy is not available, it has become increasingly expensive, and it requires a relatively large quantity of serum.
An alternative test has recently been developed for FIV. 2 This enzyme-linked immunosorbent assay (ELISA) uses peptides that are reportedly conserved among envelope proteins from many FIV strains. 12, 13 Potential advantages of this test include lower cost and a requirement for less serum while maintaining high specificity and sensitivity. In addition, the ELISA format offers the opportunity to determine the antibody titer of specific immunoglobulin isotypes.
Lentiviruses related to FIV have been identified in nondomestic felids. 3, 5, 6, 10, 11 The epidemiology of these viruses in domestic and nondomestic felids has been difficult to study. Western blots 6,11 and the only commercial assay for FIV currently available in the United States a,10 do not distinguish between antibodies to FIV and those to lentiviruses of nondomestic felids. Genomic sequence analysis of lentiviruses isolated from domestic cats, pumas, and lions has shown, however, that these viruses are distinct. 6 If the peptides from lentiviruses of nondomestic felids are as highly conserved as their FIV homologs, they could form the basis for an assay that will be useful for the diagnosis of lentivirus infection in nondomestic felids and for distinguishing serologically between different species of lentivirus. To test this hypothesis, we have identified a puma lentivirus (PLV) membrane peptide corresponding to a highly conserved FIV envelope epitope and studied its reactivity with sera from lentivirusinfected domestic and nondomestic felids.
We report the use of a peptide ELISA to detect antibodies in sera from felids suspected of feline lentivirus infection, to study the isotype specificity of that reactivity, and to examine the ability of the envelope protein peptide ELISA to distinguish serologic reactivity of PLV and FIV antibodies. ing to P237 was designed for this study. The FIV peptides b and PLV peptide c were produced by commercial laboratories.
Methods and materials
PLV peptide selection. The PLV envelope peptide selected for this study was designed to correspond to a conserved motif common to envelope glycoproteins present on all retroviruses studied to date 18 and represented in FIV by the P237 peptide. This correspondence was accomplished, using genetic analysis software, d,7 by aligning the amino acids predicted from the open reading frames of membrane proteins encoded by cDNA for human immunodeficiency virus (HIV)-1, HIV-2, FIV, and PLV envelope proteins (Table 1) . All four viruses share a common peptide motif located on a similar region of the envelope protein, which begins and ends with cysteine residues and is located on a similar region of the envelope protein. The PLV peptide used for this study was CPFKDICQL, which includes amino acids 610-618 (GenBank no. U03983). 9 ELISA. Peptide ELISAs were done as described elsewhere 2 with modifications. The volume of each reagent was 100 µl/ well. The optimal concentration of peptide antigens was determined over the range of 1-20 µg/ml using negative and positive sera identified by western blot. Peptides at a concentration of 10 µg/ml in phosphate-buffered saline (PBS) were bound to ELISA plates e overnight at 4 C. The plates were washed 3 times with PBS containing 0.05% polyoxyethylenesorbitan monolaurate (PBSTW) and soaked for 30 min at room temperature with PBSTW. Serum samples diluted 1:25 in PBSTW were incubated for 60 min at 37 C. This concentration of serum was determined to be optimal from serum titration experiments over the range of 1:5 through 1:50 dilutions using negative and positive sera identified by western blot. After 3 washes with PBSTW, peroxidase-conjugated isotype-specific goat anti-cat antibody, f diluted 1:300 in PBSTW, was added and incubated at 37 C for 1 hr. The plates were washed 3 times with PBSTW and once with PBS and then received 2,2'-azino-bis(2-ethylbenzthiazoline-6sulfonic acid) g (ABTS) substrate dissolved in 0.05 M phosphate-citrate buffer (pH 5.0). Each 100 ml of substrate solution contained 20 mg of ABTS and 40 µl of 30% hydrogen peroxide. The optical density of the solution in each well was determined at 405 nm. h A total of 56 cat sera reactive with FIV in the western blot assay were studied. Twenty-five western blot-negative sera were used as controls. All samples were tested for reactivity with the P237 antigen, and when sufficient quantities of serum were available the samples were tested also with P240 and P241 peptides and by the commercial EIA. Samples were considered positive by ELISA with a specific FIV peptide if their optical density (OD) was greater than the mean OD of the corresponding western blotnegative samples plus 3 standard deviations (negative mean plus 3 SD).
Felid sera. Domestic cat (Felis catus) sera used in this study were received for FIV antibody testing at the University of Tennessee College of Veterinary Medicine Serology Laboratory and also by a commercial diagnostic laboratory. i Sera from nondomestic felids, j characterized by western blot with FIV antigen, consisted of samples from serologically negative felids, including Acinonyx jubatus (cheetah), Felis concolor (panther), Panthera onca (jaguar), P. pardus (leopard), and three P. tigris (tigers). Lentivirus-positive sera with antibody reactive to FIV were from a F. concolor subspecies coryi (Florida panther), F. concolor (cougar), F. manul (Pallas cat), P. leo (lion), and two P. tigris.
Western blots. Blots were done with the Petaluma strain of FIV 14,20 essentially as described elsewhere. 15 Sera, diluted 1:50, were reacted with electrophoresed FIV antigens on nitrocellulose membranes and then with peroxidase-conjugated affinity-isolated rabbit anti-cat IgG f and 4-chloro 1-napthol substrate g prepared in 128 mM sodium chloride and 418 mM triethanolamine (pH 7.5) containing hydrogen peroxide.
Peptide sequence analysis. Sequences reported in Gen-Bank, Swiss Protein, and Protein Identification Resource (PIR) databases with the following accession numbers were compared with P237, P240, and P241: L00607, L06135, M25381, M73964, M73965, P16090, P19030, PQ0619, PQ0620, PQ0621, PQ0622, PQ0623, PQ0624, PQ0625, PQ0626, Q02282, Q03804, Q04993, Q04995, S19886, S23823, S29946, S29947, S29948, S29949, S29950, S29951, S29952, S29953, S29955, U02392, U02393, U02394, U02395, U02396, U02397, U02398, U02399, U02400, U02401, U02402, U02403, U02405, U02406, U02410, U02411, U02412, U02413, U02414, U02415, U02416, U02417, U02418, U02419, U02420, U02421, U02422, U11820.
Results
Western blot-positive domestic cat samples had IgG reactive with P237 with 2 exceptions (Table 2). One sample that did not have IgG or IgM reactivity with P237, P240, or P241 was positive by western blot and commercial EIA. Another sample that was negative for IgG antibody reactive with the FIV oligopeptides did have strong IgM reactivity with P237. The usefulness of IgM for diagnosis is questionable, however, because fewer than half of the western blot-positive sera had IgM reactive with P237, P240, or P241.
The percentage of western blot-positive cats that had IgG reactive with P240 and P241 was much lower than the percentage reactive with P237. Only 1 of the western blot-negative samples reacted with P237, and its OD was just 0.002 above the cutoff for negative samples. None of the other western blot-negative samples contained IgG or IgM reactive with the FIV peptides used in this study.
The results of the western blot and commercial EIA were identical for positive samples. One of the commercial EIA positive samples tested negative by western blot, did not react with any of the FIV peptides, and was considered a false-positive result. Compared with the FIV western blot, the relative sensitivity of the peptide ELISA with P237 antigen for IgG was 96.4% and the relative specificity of this assay was 96%. The commercial EIA had a sensitivity of 100% (36 of 36) and a specificity of 95.6% (1 false positive of 23 samples) as compared with the western blot.
Analysis of the FIV envelope protein deduced from available sequences (Table 3) showed that the P237 peptide is highly conserved. However, P240 and P241 are identical to reported sequences in only 62.1% and 30.7% of the cases, respectively. A PLV envelope peptide corresponding to a cysteine loop-forming region present in HIV-1, HIV-2, and FIV was identified by protein sequence homology (Table  1) . Sera from the three lentivirus-infected nondomestic Felis species, including a cougar, Florida panther, and Pallas cat, had strong reactivity with the PLV peptides lentivirus-infected Panthera species, including a tiger, SD = 0.047). Nondomestic lentivirus-negative (determined by western blot) felids did not react with the PLV peptide (n = 7, = 0.085, range = 0.005-0.133). Likewise, none of the FIV-negative domestic cat sera had IgG reactive with the PLV peptide. One FIV-negative cat, however, had IgM strongly reactive with the PLV peptide. None of the PLV-positive animals had IgG reactive with the P237 FIV peptide, and none of the FIV samples had IgG reactive with the PLV peptide.
Discussion
The reactivity of sera from domestic cats and nondomestic felids with lentivirus envelope protein peptides was examined. Cat sera used in this study were submitted for the diagnosis of disease in patients suspected of being infected with FIV. As such, this was a realistic test of the ability of the peptide ELISA to detect FIV infection in a clinical setting. Because the peptide ELISA requires 4 µl of serum/well, samples can be tested in triplicate with only 12 µl of serum as compared with the 100 µl of serum required for a single test using the commercial EIA. The results of this study indicate that the P237 peptide is immunogenic and highly conserved among FIV-infected domestic cats in the USA. Only about 50% of the FIV-positive domestic cats, however, had IgG reactive with the P240 and P241 peptides and even fewer had IgM that reacted with these peptides. This result may be due to poor immunogenicity and/or a lack of antigenic conservation. The role for antigenic variation is supported by the fact that of the reported FIV envelope protein sequences deduced from cDNA, 9 of 13 sequences (69%) differ from the P241 peptide and 22 of 58 sequences (38%) differ from the P240 peptide. This finding is expected because the FIV envelope protein shows extensive sequence variation. 8 The P237 peptide, however, appears to be highly conserved. The 9 amino acids comprising the peptide used for this study are identical in each of the 15 envelope sequences currently reported on Genbank, Swiss Protein, and PIR sequence databases, with the exception of P19030, 16 which differs at 1 amino acid. This difference is the substitution of an E for a K in position 705. This change is not likely to significantly alter serologic reactivity with the P237 peptide (CNQNQFFCK) because the sequence still contains the pentapeptide QNQFF, which has been identified as the sequence required for reactivity. 2 The highly conserved nature of this protein may be a result of its role in posttranslational processing. The P237 peptide is predicted to form a cysteine loop, 13 a feature that appears to be common to all retroviruses for which the amino acid sequence is known. 19 This structure is apparently necessary for the posttranslational cleavage of the envelope glycoprotein precursor. 17 A corresponding peptide that we identified from a sequence of PLV, 11 CPFKDICQL, reacts with sera from FIV western blot-seropositive nondomestic Felis species but not with uninfected Felis species, FIV-positive or-negative domestic cats, or Panthera species. The failure of antibodies from lentivirus-infected Panthera species to react with the PLV peptide is not surprising because there is extensive sequence divergence between lentiviruses infecting pumas (F. concolor) and those infecting lions (P. leo). 6 Because the western blot and EIA currently used for diagnosis of FIV and PLV apparently cannot distinguish between the 2 viruses, 10 tests based upon the FIV and PLV peptides should be useful to detect the introduction of FIV into exotic felids or of lentiviruses from nondomestic felids into the domestic cat population and possibly to distinguish groups of lentiviruses infecting nondomestic felids. An accurate, inexpensive, and rapid test for lentivirus antibodies could also facilitate management decisions for captive and wild populations of nondomestic felids.
